ADAR1 Capital Management, LLC

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1940272
Institutional-grade research for retail investors

13F Reported Value

$1.7B

incl. option notional

Equity Holdings

$1.7B

Option Notional

$34.7M

$12.5M puts / $22.2M calls

Holdings

310

Latest Filing

2026-03-31

Filing Quarter

Q1 2026

Portfolio Overview

ADAR1 Capital Management, LLC disclosed 310 positions worth $1.7B in its Form 13F-HR for Q1 2026$1.7B in common stock plus $34.7M of put/call option positions (reported at underlying notional value, not premium at risk), led by $ABVX (Abivax S.A.) at 9.3% of the equity portfolio, followed by $PTGX and $ROIV. During the quarter the fund opened 78 new positions and exited 40 — including a new stake in $BEAM and a full exit from $RAPT. The portfolio is most concentrated in Healthcare (89.7% of disclosed assets). All figures are sourced directly from ADAR1 Capital Management, LLC’s Form 13F-HR filing with the SEC under CIK 1940272.

Sector Allocation

HealthcareOtherFinancialsTechnologyConsumer DiscretionaryIndustrials

AUM History

Top Equity Holdings by Value

Option Positions

13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.

$TERNCALL$11M notional
ISHARES TR - RUSSELL 2000 ETFPUT$7M notional
$ABVXCALL$5M notional
$LQDAPUT$4M notional
SPDR SERIES TRUST - STATE STREET SPDPUT$2M notional
$QURECALL$2M notional
$KPTICALL$1M notional
$KVACCALL$900K notional
$REPLCALL$765K notional
$GUTSCALL$654K notional
$NVOCALL$478K notional
$RARECALL$419K notional

Quarterly Activity — Q1 2026

Click any card to unlock

Top Holdings

AI Quality Scored

Unlock AI quality scores for every holding

32-signal composite ranking on each of ADAR1 Capital Management, LLC's 310 positions.

Showing top 10 of 310 holdings.

Sector Allocation

Healthcare

$1.5B

Other

$137.7M

Financials

$18.4M

Technology

$8.2M

Consumer Discretionary

$2.1M

Industrials

$1.8M

Materials

$1.3M

Consumer Staples

$1.0M

Full Holdings — ADAR1 Capital Management, LLC (Q1 2026)

All 310 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.

#TickerCompanyValueWeightQoQQuality
1ABVX$ABVXAbivax S.A.$155.2M9.3%-47%
2PTGX$PTGXProtagonist Therapeutics, Inc$104.8M6.3%-53%24.8
3ROIV$ROIVRoivant Sciences Ltd.$91.0M5.5%-52%
4IMVT$IMVTImmunovant, Inc.$66.5M4.0%-46%
5SPY$SPYSPDR S&P 500 ETF TRUST$49.4M3.0%-31%
6TERN$TERNTerns Pharmaceuticals, Inc.$48.2M2.9%-16%
7CYTK$CYTKCYTOKINETICS INC$41.7M2.5%-41%28
8CRNX$CRNXCrinetics Pharmaceuticals, Inc.$41.4M2.5%+84%26.5
9EA SERIES TRUST - ALPHA ARCH 1-3$39.2M2.4%-50%
10DNLI$DNLIDenali Therapeutics Inc.$35.9M2.2%+1695%
11BEAM$BEAMBeam Therapeutics Inc.$34.5M2.1%NEW12.1
12ZLAB$ZLABZai Lab Ltd$26.8M1.6%-43%
13SEPN$SEPNSepterna, Inc.$26.2M1.6%-53%44.6
14VIR$VIRVir Biotechnology, Inc.$24.6M1.5%NEW5.6
15DBVT$DBVTDBV Technologies S.A.$21.2M1.3%NEW6.1
16AVR$AVRAnteris Technologies Global Corp.$21.0M1.3%+53%
17INSP$INSPInspire Medical Systems, Inc.$20.9M1.3%+1251%46
18SRRK$SRRKScholar Rock Holding Corp$20.0M1.2%+193%
19RYTM$RYTMRHYTHM PHARMACEUTICALS, INC.$18.4M1.1%+106%30.3
20SYRE$SYRESpyre Therapeutics, Inc.$17.1M1.0%+397%
21CTMX$CTMXCytomX Therapeutics, Inc.$16.0M1.0%-59%19.1
22PROTHENA CORP PLC - SHS$15.4M0.9%-46%
23SNY$SNYSanofi$15.3M0.9%+150%
24PCVX$PCVXVaxcyte, Inc.$15.1M0.9%-59%
25MNPR$MNPRMonopar Therapeutics$14.5M0.9%-44%
26ABUS$ABUSArbutus Biopharma Corp$14.1M0.8%-71%
27AMLX$AMLXAmylyx Pharmaceuticals, Inc.$13.9M0.8%-44%
28CLDX$CLDXCelldex Therapeutics, Inc.$13.6M0.8%-67%13.2
29TSHA$TSHATaysha Gene Therapies, Inc.$13.3M0.8%-40%4.1
30XENE$XENEXenon Pharmaceuticals Inc.$13.3M0.8%-44%12.9
31STRO$STROSUTRO BIOPHARMA, INC.$13.1M0.8%+291%30.1
32RVMD$RVMDRevolution Medicines, Inc.$13.0M0.8%-54%
33ELVN$ELVNEnliven Therapeutics, Inc.$12.9M0.8%+449%
34CGON$CGONCG Oncology, Inc.$12.6M0.8%-64%28
35SPDR SERIES TRUST - STATE STREET SPD$12.4M0.8%-50%
36ESTA$ESTAESTABLISHMENT LABS HOLDINGS INC.$12.1M0.7%-38%26.7
37REPL$REPLReplimune Group, Inc.$12.1M0.7%-36%
38IVA$IVAInventiva S.A.$12.1M0.7%-60%
39IONS$IONSIONIS PHARMACEUTICALS INC$12.0M0.7%-46%37.1
40NKTR$NKTRNEKTAR THERAPEUTICS$11.6M0.7%+12%10.2
41IKT$IKTInhibikase Therapeutics, Inc.$11.1M0.7%-59%
42SPRY$SPRYARS Pharmaceuticals, Inc.$10.9M0.7%+84%29.7
43TERN$TERNCALLTerns Pharmaceuticals, Inc.$10.5MNEW
44HELIX ACQUISITION CORP III - USD CL A ORD SHS$10.3M0.6%NEW
45OVID$OVIDOvid Therapeutics Inc.$10.1M0.6%-47%13.1
46OKUR$OKUROnKure Therapeutics, Inc.$10.1M0.6%+20%
47REGN$REGNREGENERON PHARMACEUTICALS, INC.$9.4M0.6%-50%75.1
48MLTX$MLTXMoonLake Immunotherapeutics$8.5M0.5%NEW
49LXEO$LXEOLexeo Therapeutics, Inc.$8.4M0.5%-47%
50IRD$IRDOpus Genetics, Inc.$8.4M0.5%+2211%
51TEVA$TEVATEVA PHARMACEUTICAL INDUSTRIES LTD$8.1M0.5%-43%
52SVRA$SVRASavara Inc$8.0M0.5%-48%
53MPLT$MPLTMapLight Therapeutics, Inc.$7.6M0.5%NEW
54LONA$LONALeonaBio, Inc.$7.5M0.5%-8%
55EQ$EQEquillium, Inc.$7.5M0.5%-67%27.2
56VKTX$VKTXViking Therapeutics, Inc.$7.4M0.5%+330%
57DMRA$DMRADamora Therapeutics, Inc.$7.2M0.4%NEW
58URGN$URGNUroGen Pharma Ltd.$7.1M0.4%+58%
59BBIO$BBIOBridgeBio Pharma, Inc.$7.0M0.4%-78%31.7
60PRME$PRMEPrime Medicine, Inc.$6.9M0.4%NEW11.2
61ISHARES TR - RUSSELL 2000 ETF$6.8M-50%
62VRTX$VRTXVERTEX PHARMACEUTICALS INC / MA$6.7M0.4%-45%76.6
63KRRO$KRROKorro Bio, Inc.$6.1M0.4%NEW5.8
64VRDN$VRDNViridian Therapeutics, Inc.\DE$6.0M0.4%+97%30.5
65DHR$DHRDANAHER CORP /DE/$5.9M0.3%-40%63.9
66INSM$INSMINSMED Inc$5.8M0.3%NEW29.4
67ASND$ASNDAscendis Pharma A/S$5.7M0.3%-51%41.5
68BHF$BHFBrighthouse Financial, Inc.$5.7M0.3%-50%54.9
69SRPT$SRPTSarepta Therapeutics, Inc.$5.7M0.3%+354%41.6
70OACC$OACCOaktree Acquisition Corp. III Life Sciences$5.5M0.3%-50%
71PCSC$PCSCPerceptive Capital Solutions Corp$5.5M0.3%-79%
72KRYS$KRYSKrystal Biotech, Inc.$5.2M0.3%-50%75.9
73ABOS$ABOSAcumen Pharmaceuticals, Inc.$5.1M0.3%+21%
74IVVD$IVVDInvivyd, Inc.$5.0M0.3%-51%25.7
75BBIO$BBIOBridgeBio Pharma, Inc.$4.9M0.3%NEW31.7
76BHAV ACQUISITION CORP - UNIT 03/18/2031$4.9M0.3%NEW
77TARA$TARAProtara Therapeutics, Inc.$4.9M0.3%-59%
78ABVX$ABVXCALLAbivax S.A.$4.9MNEW
79BRIDGEBIO PHARMA INC - NOTE 1.750% 3/0$4.9M0.3%NEW
80AGIO$AGIOAGIOS PHARMACEUTICALS, INC.$4.8M0.3%-63%26.3
81LLY$LLYELI LILLY & Co$4.7M0.3%NEW89.3
82DNTH$DNTHDianthus Therapeutics, Inc. /DE/$4.6M0.3%NEW26.8
83ARWR$ARWRARROWHEAD PHARMACEUTICALS, INC.$4.4M0.3%-40%74.4
84BLTE$BLTEBELITE BIO, INC$4.3M0.3%-66%
85EVMN$EVMNEvommune, Inc.$4.2M0.3%-50%
86MLYS$MLYSMineralys Therapeutics, Inc.$4.2M0.3%-43%
87JANX$JANXJanux Therapeutics, Inc.$4.1M0.3%-39%24.8
88CLYM$CLYMClimb Bio, Inc.$4.1M0.3%-79%
89PALI$PALIPALISADE BIO, INC.$4.0M0.2%-44%
90AEXA$AEXAAmerican Exceptionalism Acquisition Corp. A$3.9M0.2%-50%
91SPRB$SPRBSPRUCE BIOSCIENCES, INC.$3.8M0.2%-49%
92NAMS$NAMSNewAmsterdam Pharma Co N.V.$3.8M0.2%-50%
93LQDA$LQDAPUTLiquidia Corp$3.8M+104%37.4
94ZURA$ZURAZura Bio Ltd$3.8M0.2%-44%
95ACLX$ACLXArcellx, Inc.$3.7M0.2%-49%6.7
96CTNM$CTNMContineum Therapeutics, Inc.$3.6M0.2%-50%
97BBIO$BBIOBridgeBio Pharma, Inc.$3.6M0.2%NEW31.7
98GLUE$GLUEMonte Rosa Therapeutics, Inc.$3.5M0.2%-50%18.1
99ONC$ONCBeOne Medicines Ltd.$3.5M0.2%NEW
100TENX$TENXTENAX THERAPEUTICS, INC.$3.4M0.2%+68%
101AVBP$AVBPArriVent BioPharma, Inc.$3.3M0.2%NEW
102PLRX$PLRXPLIANT THERAPEUTICS, INC.$3.3M0.2%+1651%
103ATAI$ATAIAtai Beckley N.V.$3.2M0.2%-50%
104RLMD$RLMDRELMADA THERAPEUTICS, INC.$3.1M0.2%+632%
105CATX$CATXPerspective Therapeutics, Inc.$3.1M0.2%+294%
106CRBP$CRBPCorbus Pharmaceuticals Holdings, Inc.$3.1M0.2%-42%
107ELDN$ELDNEledon Pharmaceuticals, Inc.$3.0M0.2%-73%
108PHVS$PHVSPharvaris N.V.$3.0M0.2%-38%
109APLS$APLSApellis Pharmaceuticals, Inc.$2.9M0.2%+81%63.9
110EWTX$EWTXEdgewise Therapeutics, Inc.$2.9M0.2%-50%
111PEPG$PEPGPepGen Inc.$2.8M0.2%+2082%
112CAPR$CAPRCAPRICOR THERAPEUTICS, INC.$2.8M0.2%NEW
113MASI$MASIMASIMO CORP$2.7M0.2%-50%47.1
114INO$INOINOVIO PHARMACEUTICALS, INC.$2.6M0.1%-51%
115TFX$TFXTELEFLEX INC$2.5M0.1%-87%30.5
116DRUG$DRUGBRIGHT MINDS BIOSCIENCES INC.$2.5M0.1%+384%
117BIOA$BIOABioAge Labs, Inc.$2.4M0.1%-50%28.6
118ALEC$ALECAlector, Inc.$2.3M0.1%-53%8.9
119PFE$PFEPFIZER INC$2.2M0.1%-47%69
120DCTH$DCTHDELCATH SYSTEMS, INC.$2.1M0.1%-50%54.9
121BIIB$BIIBBIOGEN INC.$2.0M0.1%-77%65.6
122CNTB$CNTBConnect Biopharma Holdings Ltd$1.9M0.1%NEW
123SPDR SERIES TRUST - STATE STREET SPD$1.9MNEW
124SMMT$SMMTSummit Therapeutics Inc.$1.7M0.1%-50%
125GMED$GMEDGLOBUS MEDICAL INC$1.7M0.1%-50%77.6
126ALKS$ALKSAlkermes plc.$1.6M0.1%-64%
127QURE$QURECALLuniQure N.V.$1.6M+67%
128SLNO$SLNOSOLENO THERAPEUTICS INC$1.6M0.1%-44%46.3
129CCII$CCIICohen Circle Acquisition Corp. II$1.6M0.1%-50%
130RCKT$RCKTROCKET PHARMACEUTICALS, INC.$1.5M0.1%-55%
131SUPN$SUPNSUPERNUS PHARMACEUTICALS, INC.$1.5M0.1%-50%45.3
132CNTA$CNTACentessa Pharmaceuticals plc$1.5M0.1%-50%
133FOLD$FOLDAMICUS THERAPEUTICS, INC.$1.5M0.1%NEW44.2
134MAZE$MAZEMaze Therapeutics, Inc.$1.5M0.1%-86%19.7
135UNH$UNHUNITEDHEALTH GROUP INC$1.5M0.1%NEW66.8
136ADGM$ADGMAdagio Medical Holdings, Inc.$1.4M0.1%-48%
137FWRD$FWRDFORWARD AIR CORP$1.3M0.1%+47%52.4
138SXT$SXTSENSIENT TECHNOLOGIES CORP$1.3M0.1%NEW57.3
139KNSA$KNSAKiniksa Pharmaceuticals International, plc$1.3M0.1%-53%
140CRVS$CRVSCorvus Pharmaceuticals, Inc.$1.3M0.1%-91%
141MSLE$MSLESatellos Bioscience Inc.$1.3M0.1%NEW
142QURE$QUREuniQure N.V.$1.2M0.1%-84%
143NVO$NVONOVO NORDISK A S$1.2M0.1%NEW
144PMN$PMNProMIS Neurosciences Inc.$1.2M0.1%NEW
145LXRX$LXRXLEXICON PHARMACEUTICALS, INC.$1.2M0.1%NEW33.1
146SDGR$SDGRSchrodinger, Inc.$1.2M0.1%NEW31
147KPTI$KPTICALLKaryopharm Therapeutics Inc.$1.1MNEW20.4
148XNCR$XNCRXencor Inc$1.1M0.1%-17%13.1
149OABI$OABIOmniAb, Inc.$1.1M0.1%-50%9.7
150FDMT$FDMT4D Molecular Therapeutics, Inc.$1.1M0.1%-50%23.2
151KROS$KROSKeros Therapeutics, Inc.$1.1M0.1%+158%57.2
152DAWN$DAWNDay One Biopharmaceuticals, Inc.$1.1M0.1%NEW42.6
153BMY$BMYBRISTOL MYERS SQUIBB CO$1.1M0.1%-56%70.1
154TNGX$TNGXTango Therapeutics, Inc.$1.0M0.1%-82%26.9
155TNYA$TNYATenaya Therapeutics, Inc.$1.0M0.1%-50%
156BSAA$BSAABEST SPAC I Acquisition Corp.$1.0M0.1%-50%
157MCK$MCKMCKESSON CORP$1.0M0.1%-50%63.7
158BMRN$BMRNBIOMARIN PHARMACEUTICAL INC$1.0M0.1%-29%74.1
159ARROWHEAD PHARMACEUTICALS IN - NOTE 1/1$1.0M0.1%NEW
160ORKA$ORKAOruka Therapeutics, Inc.$1.0M0.1%-50%
161EA$EAELECTRONIC ARTS INC.$1.0M0.1%-50%71.1
162FULC$FULCFulcrum Therapeutics, Inc.$1.0M0.1%-95%
163BCRX$BCRXBIOCRYST PHARMACEUTICALS INC$999,6000.1%+17%37.2
164GH$GHGuardant Health, Inc.$923,7000.1%-29%36.1
165CBIO$CBIOCRESCENT BIOPHARMA, INC.$923,5150.1%-96%28
166CNTX$CNTXContext Therapeutics Inc.$919,8660.1%-50%
167ENGN$ENGNenGene Therapeutics Inc.$910,4020.1%-78%
168SLN$SLNSilence Therapeutics plc$907,2670.1%+264%
169ARE$AREALEXANDRIA REAL ESTATE EQUITIES, INC.$905,1900.1%-40%45.1
170KVAC$KVACCALLKeen Vision Acquisition Corp.$900,000-50%
171IBIO$IBIOiBio, Inc.$892,7680.1%-42%
172BNTX$BNTXBioNTech SE$888,8000.1%-50%
173GILD$GILDGILEAD SCIENCES, INC.$885,1390.1%-52%77.8
174NRIX$NRIXNurix Therapeutics, Inc.$869,0850.1%-61%13.2
175DYN$DYNDyne Therapeutics, Inc.$860,5040.1%-44%
176ISRG$ISRGINTUITIVE SURGICAL INC$843,6120.1%-10%81.4
177ANL$ANLAdlai Nortye Ltd.$815,9300.1%NEW
178WW$WWWW INTERNATIONAL, INC.$792,7980.1%-49%26.4
179RNA$RNAAvidity Biosciences, Inc.$771,0000.1%-95%22.3
180ITGR$ITGRInteger Holdings Corp$770,0000.1%NEW50.2
181REPL$REPLCALLReplimune Group, Inc.$765,000+100%
182KPTI$KPTIKaryopharm Therapeutics Inc.$761,6200.1%+37%20.4
183CMPX$CMPXCompass Therapeutics, Inc.$735,3100.0%-50%
184NUVL$NUVLNuvalent, Inc.$711,2080.0%-49%
185CGEM$CGEMCullinan Therapeutics, Inc.$710,5000.0%-50%
186IDYA$IDYAIDEAYA Biosciences, Inc.$666,4000.0%-50%10.5
187GUTS$GUTSCALLFRACTYL HEALTH, INC.$654,000-50%
188ENTA$ENTAENANTA PHARMACEUTICALS INC$648,6390.0%-38%15.5
189VERA$VERAVera Therapeutics, Inc.$645,0080.0%-46%
190VYNE$VYNEVYNE Therapeutics Inc.$635,6800.0%+110%
191BSX$BSXBOSTON SCIENTIFIC CORP$627,5000.0%+0%79.9
192AVTR$AVTRAvantor, Inc.$627,2000.0%-43%38.4
193ARVN$ARVNARVINAS, INC.$610,4650.0%-50%13.9
194KZR$KZRKezar Life Sciences, Inc.$607,9430.0%-65%
195KLRS$KLRSKalaris Therapeutics, Inc.$577,0000.0%-50%
196MIRM$MIRMMirum Pharmaceuticals, Inc.$572,7560.0%NEW32.7
197JAZZ$JAZZJazz Pharmaceuticals plc$567,1500.0%-81%
198ASMB$ASMBASSEMBLY BIOSCIENCES, INC.$553,5290.0%-49%26.6
199PRLD$PRLDPrelude Therapeutics Inc$522,6620.0%NEW27
200GTERA$GTERAGloba Terra Acquisition Corp$518,0000.0%-50%
201WT$WTWisdomTree, Inc.$503,4000.0%-50%62.9
202ACRS$ACRSAclaris Therapeutics, Inc.$496,5980.0%-89%9.2
203PRAX$PRAXPraxis Precision Medicines, Inc.$483,2850.0%-50%
204LUNG$LUNGPulmonx Corp$483,1010.0%-47%23.9
205ELAN$ELANElanco Animal Health Inc$478,6000.0%-50%52.2
206NVO$NVOCALLNOVO NORDISK A S$477,750NEW
207PHAT$PHATPhathom Pharmaceuticals, Inc.$476,6190.0%-50%32.5
208MDGL$MDGLMADRIGAL PHARMACEUTICALS, INC.$468,5060.0%-50%25.4
209PYPD$PYPDPolyPid Ltd.$455,3010.0%-50%
210BABA$BABAAlibaba Group Holding Ltd$448,8960.0%-50%
211CORZ$CORZCore Scientific, Inc./tx$448,8000.0%-50%14
212WHWK$WHWKWhitehawk Therapeutics, Inc.$443,3350.0%-17%9.6
213NTRA$NTRANatera, Inc.$429,3790.0%-50%46.4
214VTGN$VTGNVistagen Therapeutics, Inc.$429,2770.0%-40%
215TXMD$TXMDTherapeuticsMD, Inc.$422,6040.0%-50%
216RARE$RARECALLUltragenyx Pharmaceutical Inc.$419,000+0%31
217SNDX$SNDXSyndax Pharmaceuticals Inc$408,8000.0%-27%30
218TECX$TECXTectonic Therapeutic, Inc.$401,8610.0%-78%
219TRDA$TRDAEntrada Therapeutics, Inc.$384,9100.0%NEW8.5
220BHVN$BHVNBiohaven Ltd.$378,8130.0%-35%
221MRK$MRKMerck & Co., Inc.$377,7110.0%-84%70.9
222VSTM$VSTMVerastem, Inc.$376,8300.0%NEW40.8
223MLTX$MLTXCALLMoonLake Immunotherapeutics$372,800NEW
224RGNX$RGNXREGENXBIO Inc.$372,2060.0%-85%26.9
225ACET$ACETAdicet Bio, Inc.$366,5620.0%-79%
226LEGN$LEGNLegend Biotech Corp$361,8000.0%NEW44.2
227SRZN$SRZNSurrozen, Inc./DE$349,5600.0%NEW
228ZNTL$ZNTLZentalis Pharmaceuticals, Inc.$338,4480.0%-10%
229BCYC$BCYCBICYCLE THERAPEUTICS PLC$330,8230.0%NEW
230NBIX$NBIXNEUROCRINE BIOSCIENCES INC$329,3500.0%NEW75.4
231CRBP$CRBPCALLCorbus Pharmaceuticals Holdings, Inc.$328,650NEW
232WVE$WVEWave Life Sciences Ltd.$325,5250.0%NEW
233KURA$KURAKura Oncology, Inc.$325,2000.0%-50%9.1
234KPRX$KPRXKIORA PHARMACEUTICALS INC$324,1260.0%-50%
235CORT$CORTCORCEPT THERAPEUTICS INC$322,4800.0%NEW55.4
236UPB$UPBUpstream Bio, Inc.$315,0000.0%NEW22.6
237KIDS$KIDSORTHOPEDIATRICS CORP$314,9400.0%-50%33.4
238ANNX$ANNXAnnexon, Inc.$304,7000.0%-43%
239GERN$GERNGERON CORP$298,0000.0%-70%
240JD$JDJD.com, Inc.$295,7000.0%-50%
241PMVP$PMVPPMV Pharmaceuticals, Inc.$286,4500.0%+14%
242TRAW$TRAWTraws Pharma, Inc.$281,9990.0%-50%
243JBIO$JBIOJade Biosciences, Inc.$281,0000.0%-52%
244RARE$RAREUltragenyx Pharmaceutical Inc.$280,7300.0%NEW31
245PCAP$PCAPProCap Acquisition Corp$278,5600.0%-50%
246BCAX$BCAXBicara Therapeutics Inc.$272,5920.0%-50%
247RXST$RXSTRxSight, Inc.$266,4200.0%-1%32
248PANW$PANWPalo Alto Networks Inc$256,5120.0%NEW66.5
249NTLA$NTLAIntellia Therapeutics, Inc.$250,2080.0%NEW24.5
250CRWD$CRWDCrowdStrike Holdings, Inc.$249,8620.0%NEW55
251RBRK$RBRKRubrik, Inc.$239,9530.0%NEW49.5
252RPRX$RPRXRoyalty Pharma plc$239,8500.0%NEW
253SGRY$SGRYSurgery Partners, Inc.$238,4000.0%-50%48
254LRMR$LRMRLarimar Therapeutics, Inc.$237,3530.0%-86%
255EOLS$EOLSEvolus, Inc.$229,5800.0%-22%30
256QTTB$QTTBQ32 Bio Inc.$224,7000.0%-13%23.1
257LGVN$LGVNLongeveron Inc.$208,0000.0%NEW
258ANAB$ANABANAPTYSBIO, INC$205,0910.0%NEW29.4
259CANTOR EQUITY PARTNERS VI IN - CL A ORD SHS$202,0000.0%NEW
260KALV$KALVKalVista Pharmaceuticals, Inc.$201,3000.0%-50%25.9
261KYTX$KYTXKyverna Therapeutics, Inc.$193,5540.0%-80%
262NUVB$NUVBNuvation Bio Inc.$186,6150.0%NEW29.5
263BNTC$BNTCBenitec Biopharma Inc.$186,3750.0%NEW
264LPCN$LPCNLipocine Inc.$185,2080.0%NEW
265RLYB$RLYBRallybio Corp$184,1990.0%NEW
266RZLT$RZLTRezolute, Inc.$178,9710.0%-24%
267QCLS$QCLSQ/C TECHNOLOGIES, INC.$172,5000.0%NEW
268ERAS$ERASErasca, Inc.$161,8000.0%NEW
269COYA$COYACoya Therapeutics, Inc.$161,1460.0%NEW
270PSNL$PSNLPersonalis, Inc.$159,2500.0%NEW15.7
271SIBN$SIBNSI-BONE, Inc.$158,8850.0%NEW37.7
272TOI$TOIOncology Institute, Inc.$153,5000.0%NEW37.8
273HELP$HELPCYBIN INC.$150,1340.0%-93%
274STIM$STIMNeuronetics, Inc.$145,0000.0%NEW31.3
275ARDX$ARDXARDELYX, INC.$143,1610.0%NEW35.3
276IFRX$IFRXInflaRx N.V.$141,5580.0%NEW
277ACHV$ACHVACHIEVE LIFE SCIENCES, INC.$140,5320.0%-50%
278VYGR$VYGRVoyager Therapeutics, Inc.$135,1000.0%-50%5.5
279CMMB$CMMBChemomab Therapeutics Ltd.$125,6000.0%-50%
280JSPR$JSPRJasper Therapeutics, Inc.$122,6680.0%-50%
281NEUP$NEUPNeuphoria Therapeutics Inc.$122,1000.0%-50%
282MIST$MISTMilestone Pharmaceuticals Inc.$119,0000.0%-50%
283ARCT$ARCTArcturus Therapeutics Holdings Inc.$115,8000.0%NEW12
284MGNX$MGNXMACROGENICS INC$115,6000.0%NEW31.7
285CCCC$CCCCC4 Therapeutics, Inc.$113,0900.0%NEW6.5
286RXRX$RXRXRECURSION PHARMACEUTICALS, INC.$107,4500.0%-50%13.6
287DSGN$DSGNDesign Therapeutics, Inc.$106,4000.0%NEW
288GOSS$GOSSGossamer Bio, Inc.$94,4540.0%-32%27.1
289IMMX$IMMXImmix Biopharma, Inc.$91,1000.0%-90%
290STI$STICALLSolidion Technology Inc.$85,185-50%
291LITS$LITSLite Strategy, Inc.$78,0590.0%-50%
292VERU$VERUVERU INC.$77,3500.0%-50%
293KYNB$KYNBKYNTRA BIO, INC.$70,9800.0%-50%60.7
294CLOV$CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE$70,4000.0%-59%55
295BMEA$BMEABiomea Fusion, Inc.$66,4330.0%-50%
296NMRA$NMRANeumora Therapeutics, Inc.$64,5450.0%-67%
297OGN$OGNOrganon & Co.$59,9000.0%-86%55.1
298ESPR$ESPREsperion Therapeutics, Inc.$58,6360.0%NEW34.3
299MREO$MREOMereo BioPharma Group plc$49,5000.0%-50%
300ANTX$ANTXAN2 Therapeutics, Inc.$47,4050.0%NEW
301A SPAC III ACQUISITION CORP - RIGHT 01/02/2026$42,4410.0%-50%
302AQST$AQSTAquestive Therapeutics, Inc.$41,5000.0%NEW11.7
303ATYR$ATYRaTYR PHARMA INC$39,5340.0%-50%
304BCAB$BCABBioAtla, Inc.$36,7250.0%-38%
305KALA$KALAKALA BIO, Inc.$24,4900.0%-50%
306CHRS$CHRSCoherus Oncology, Inc.$17,5190.0%-50%42.9
307PRQR$PRQRProQR Therapeutics N.V.$16,2000.0%-50%
308QNCX$QNCXQuince Therapeutics, Inc.$5,0800.0%-42%
309QNCX$QNCXPUTQuince Therapeutics, Inc.$5,070-69%
310IMUX$IMUXIMMUNIC, INC.$00.0%NEW

New Positions (78)

BEAM$BEAM Beam Therapeutics Inc.$34.5M
VIR$VIR Vir Biotechnology, Inc.$24.6M
DBVT$DBVT DBV Technologies S.A.$21.2M
TERN$TERNCALL Terns Pharmaceuticals, Inc.$10.5M
HELIX ACQUISITION CORP III - USD CL A ORD SHS$10.3M
MLTX$MLTX MoonLake Immunotherapeutics$8.5M
MPLT$MPLT MapLight Therapeutics, Inc.$7.6M
DMRA$DMRA Damora Therapeutics, Inc.$7.2M
PRME$PRME Prime Medicine, Inc.$6.9M
KRRO$KRRO Korro Bio, Inc.$6.1M
INSM$INSM INSMED Inc$5.8M
BHAV ACQUISITION CORP - UNIT 03/18/2031$4.9M
ABVX$ABVXCALL Abivax S.A.$4.9M
BRIDGEBIO PHARMA INC - NOTE 1.750% 3/0$4.9M
LLY$LLY ELI LILLY & Co$4.7M

Exited Positions (40)

RAPT$RAPT RAPT Therapeutics, Inc.
CIDARA THERAPEUTICS INC
YCY$YCY AA Mission Acquisition Corp. II
YCY$YCYCALL AA Mission Acquisition Corp. II
AVDL$AVDL AVADEL PHARMACEUTICALS PLC
ISHARES TR
BBOT$BBOT BridgeBio Oncology Therapeutics, Inc.
DVAX$DVAX DYNAVAX TECHNOLOGIES CORP
ASTRIA THERAPEUTICS INC
GRCE$GRCE Grace Therapeutics, Inc.
OLMA$OLMA Olema Pharmaceuticals, Inc.
AQST$AQSTPUT Aquestive Therapeutics, Inc.
GOSS$GOSSPUT Gossamer Bio, Inc.
OMER$OMERPUT OMEROS CORP
CHURCHILL CAP CORP X

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

Available Analysis

13F Pro tracks comprehensive institutional data for ADAR1 Capital Management, LLC including:

Full 13F portfolio with all holdings
Quarter-over-quarter position changes
Accumulation & distribution patterns
Sector allocation breakdown
Historical portfolio evolution
New positions & complete exits
Concentration analysis
Peer comparison with similar funds
AI-powered portfolio insights

Track ADAR1 Capital Management, LLC's Full Portfolio

See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for ADAR1 Capital Management, LLC and 8,700+ other institutional investors.

View Pricing

Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

AI-Powered Hedge Fund Analysis: ADAR1 Capital Management, LLC

13F Pro is an AI hedge fund tracker and stock research platform. For ADAR1 Capital Management, LLC (SEC CIK: 1940272), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in ADAR1 Capital Management, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.